会计年度:2016-06-30收入分布
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 保健品 | 288,161,492.60 | 87,554,766.70 | 200,606,725.90 | 69.62 | ||||
| 工业小计 | 2,582,914,631.02 | 1,241,167,796.64 | 1,341,746,834.38 | 51.95 | ||||
| 合计 | 7,092,726,150.71 | 5,321,649,193.14 | 1,771,076,957.57 | 24.97 | ||||
| 化学原料药 | 182,738,864.81 | 187,264,897.92 | -4,526,033.11 | -2.48 | ||||
| 化学制剂 | 1,545,155,097.05 | 630,109,672.28 | 915,045,424.77 | 59.22 | ||||
| 零售 | 533,402,413.71 | 377,737,281.03 | 155,665,132.68 | 29.18 | ||||
| 批发商业客户 | 1,302,580,748.92 | 1,246,229,655.35 | 56,351,093.57 | 4.33 | ||||
| 批发医疗客户 | 2,635,364,003.21 | 2,428,411,841.30 | 206,952,161.91 | 7.85 | ||||
| 其他 | 8,970,375.66 | 7,342,558.84 | 1,627,816.82 | 18.15 | ||||
| 其他1 | 38,464,353.85 | 28,102,618.82 | 10,361,735.03 | 26.94 | ||||
| 商业小计 | 4,471,347,165.84 | 4,052,378,777.68 | 418,968,388.16 | 9.37 | ||||
| 生物制剂 | 75,539,262.83 | 28,912,291.75 | 46,626,971.08 | 61.73 | ||||
| 中药 | 482,349,538.07 | 299,983,609.15 | 182,365,928.92 | 37.81 | ||||
会计年度:2015-12-31
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 保健品 | 556,989,604.52 | 158,002,943.42 | 398,986,661.10 | 71.63 | ||||
| 工业小计 | 6,040,222,050.88 | 2,890,487,352.75 | 3,149,734,698.13 | 52.15 | ||||
| 合计 | 15,781,727,204.26 | 11,872,435,964.60 | 3,909,291,239.66 | 24.77 | ||||
| 化学原料药 | 611,864,048.34 | 555,353,569.64 | 56,510,478.70 | 9.24 | ||||
| 化学制剂 | 3,649,249,554.47 | 1,481,278,255.10 | 2,167,971,299.37 | 59.41 | ||||
| 零售 | 997,828,570.77 | 733,142,206.44 | 264,686,364.33 | 26.53 | ||||
| 批发商业客户 | 2,420,876,391.05 | 2,305,283,423.97 | 115,592,967.08 | 4.77 | ||||
| 批发医疗客户 | 6,248,956,450.69 | 5,879,303,783.05 | 369,652,667.64 | 5.92 | ||||
| 其他 | 73,843,740.87 | 64,219,198.39 | 9,624,542.48 | 13.03 | ||||
| 其它 | 43,172,080.65 | 35,914,262.98 | 7,257,817.67 | 16.81 | ||||
| 商业小计 | 9,667,661,412.51 | 8,917,729,413.46 | 749,931,999.05 | 7.76 | ||||
| 生物制剂 | 259,429,809.91 | 76,939,414.69 | 182,490,395.22 | 70.34 | ||||
| 中药 | 919,516,952.99 | 582,998,906.91 | 336,518,046.08 | 36.60 | ||||
会计年度:2015-06-30
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 保健品 | 335,103,843.73 | 118,035,609.77 | 217,068,233.96 | 64.78 | ||||
| 合计 | 9,107,181,979.53 | 6,850,612,005.41 | 2,256,569,974.12 | 24.78 | ||||
| 零售 | 520,766,605.30 | 386,306,258.41 | 134,460,346.89 | 25.82 | ||||
| 其他 | 64,821,641.58 | 41,703,999.62 | 23,117,641.96 | 35.66 | ||||
| 其他1 | 35,559,988.37 | 34,065,354.53 | 1,494,633.84 | 4.20 | ||||
| 其中：批发 | 3,791,974,299.89 | 3,557,847,414.51 | 234,126,885.38 | 6.17 | ||||
| 其中：中药 | 574,306,367.84 | 356,044,348.43 | 218,262,019.41 | 38.00 | ||||
| 西药 | 3,784,649,232.82 | 2,356,609,020.14 | 1,428,040,212.68 | 37.73 | ||||
| 医药工业 | 4,758,881,085.97 | 2,872,392,977.96 | 1,886,488,108.01 | 39.64 | ||||
| 医药商业 | 4,312,740,905.19 | 3,944,153,672.92 | 368,587,232.27 | 8.55 | ||||
会计年度:2014-12-31
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 医药行业 | 16,404,630,245.99 | 11,900,734,315.75 | 4,503,895,930.24 | 27.46 | ||||
会计年度:2014-06-30
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 医药行业 | 8,982,243,838.57 | 6,318,671,997.35 | 2,663,571,841.22 | 29.65 | ||||
3/9 转到 
违法和不良信息举报电话：010-85650899 传真：010-85650844 邮箱：yhts@staff.hexun.com
Copyright©和讯网 北京和讯在线信息咨询服务有限公司 All Rights Reserved 版权所有 复制必究 京ICP备10021077号
Copyright©和讯网 北京和讯在线信息咨询服务有限公司 All Rights Reserved 版权所有 复制必究 京ICP备10021077号